NO156566C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner.

Info

Publication number
NO156566C
NO156566C NO803073A NO803073A NO156566C NO 156566 C NO156566 C NO 156566C NO 803073 A NO803073 A NO 803073A NO 803073 A NO803073 A NO 803073A NO 156566 C NO156566 C NO 156566C
Authority
NO
Norway
Prior art keywords
pyridine
preparation
hydroxyethylthiomethyl
pyridines
therapeutic active
Prior art date
Application number
NO803073A
Other languages
English (en)
Norwegian (no)
Other versions
NO803073L (no
NO156566B (no
Inventor
Joseph George Lombardino
Charles Armon Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO803073L publication Critical patent/NO803073L/no
Publication of NO156566B publication Critical patent/NO156566B/no
Publication of NO156566C publication Critical patent/NO156566C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO803073A 1979-10-15 1980-10-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner. NO156566C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
NO803073L NO803073L (no) 1981-04-21
NO156566B NO156566B (no) 1987-07-06
NO156566C true NO156566C (no) 1987-10-14

Family

ID=22188737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803073A NO156566C (no) 1979-10-15 1980-10-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner.

Country Status (39)

Country Link
US (1) US4246263A (ko)
JP (1) JPS5663962A (ko)
KR (2) KR840001614B1 (ko)
AR (3) AR226864A1 (ko)
AT (2) AT377513B (ko)
AU (1) AU517763B2 (ko)
BE (1) BE885709A (ko)
CA (1) CA1156231A (ko)
CH (1) CH646425A5 (ko)
CS (2) CS226020B2 (ko)
DD (2) DD154816B3 (ko)
DE (1) DE3038593A1 (ko)
DK (1) DK152427C (ko)
EG (1) EG14676A (ko)
ES (2) ES495932A0 (ko)
FI (1) FI75560C (ko)
FR (1) FR2467199A1 (ko)
GB (2) GB2061928B (ko)
GR (1) GR70311B (ko)
HK (2) HK1185A (ko)
HU (2) HU191824B (ko)
IE (1) IE50665B1 (ko)
IL (1) IL61261A (ko)
IN (2) IN154554B (ko)
IT (1) IT1195269B (ko)
KE (2) KE3461A (ko)
LU (1) LU82844A1 (ko)
MY (2) MY8500323A (ko)
NL (1) NL8005652A (ko)
NO (1) NO156566C (ko)
NZ (1) NZ195246A (ko)
PH (1) PH18277A (ko)
PL (2) PL125402B1 (ko)
PT (1) PT71917B (ko)
SE (1) SE437023B (ko)
SG (2) SG56384G (ko)
SU (2) SU1083907A3 (ko)
YU (2) YU41740B (ko)
ZA (1) ZA806306B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
JPH01502980A (ja) * 1986-06-17 1989-10-12 レイチ，スティーブン　デー ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
EP1896401B1 (en) * 2005-02-25 2013-04-10 Temple University - Of The Commonwealth System of Higher Education Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
WO2020076623A1 (en) 2018-10-08 2020-04-16 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
PH18277A (en) 1985-05-17
DK152427B (da) 1988-02-29
JPS6129342B2 (ko) 1986-07-05
FI75560C (fi) 1988-07-11
AT379801B (de) 1986-03-10
PT71917A (en) 1980-12-01
MY8500325A (en) 1985-12-31
FR2467199A1 (fr) 1981-04-17
LU82844A1 (fr) 1981-06-04
IE802125L (en) 1981-04-15
ATA268783A (de) 1985-07-15
SG56384G (en) 1985-03-08
FR2467199B1 (ko) 1984-12-28
US4246263A (en) 1981-01-20
ES505544A0 (es) 1982-08-16
KR830004263A (ko) 1983-07-09
NZ195246A (en) 1983-07-15
SU1083907A3 (ru) 1984-03-30
ES8206478A1 (es) 1982-08-16
AU6324080A (en) 1981-04-30
CH646425A5 (fr) 1984-11-30
SG69184G (en) 1985-03-15
DD154816B3 (de) 1987-05-13
AR226864A1 (es) 1982-08-31
HK66887A (en) 1987-09-25
ES8201972A1 (es) 1982-01-16
NO803073L (no) 1981-04-21
DE3038593C2 (ko) 1988-11-10
ZA806306B (en) 1981-10-28
BE885709A (fr) 1981-04-14
IE50665B1 (en) 1986-06-11
MY8500323A (en) 1985-12-31
SE437023B (sv) 1985-02-04
HU183233B (en) 1984-04-28
CA1156231A (en) 1983-11-01
YU266882A (en) 1983-09-30
GB2092133A (en) 1982-08-11
GR70311B (ko) 1982-09-08
CS226034B2 (en) 1984-03-19
AR227089A1 (es) 1982-09-15
SU1144617A3 (ru) 1985-03-07
DK403080A (da) 1981-04-16
KR840001614B1 (ko) 1984-10-11
IT8025324A0 (it) 1980-10-14
IN154554B (ko) 1984-11-10
AR227576A1 (es) 1982-11-15
AU517763B2 (en) 1981-08-27
HU191824B (en) 1987-04-28
ATA508980A (de) 1984-08-15
JPS5663962A (en) 1981-05-30
PL231782A1 (ko) 1982-03-01
SE8007193L (sv) 1981-04-16
DK152427C (da) 1988-07-25
NO156566B (no) 1987-07-06
GB2061928A (en) 1981-05-20
KR840001615B1 (ko) 1984-10-11
FI75560B (fi) 1988-03-31
PL125314B1 (en) 1983-04-30
HK1185A (en) 1985-01-11
PT71917B (en) 1983-01-10
YU41740B (en) 1987-12-31
CS226020B2 (en) 1984-03-19
IN163553B (ko) 1988-10-08
IL61261A (en) 1984-08-31
DD202543A5 (de) 1983-09-21
GB2092133B (en) 1983-03-16
IL61261A0 (en) 1980-12-31
EG14676A (en) 1985-03-31
ES495932A0 (es) 1982-01-16
IT1195269B (it) 1988-10-12
YU262680A (en) 1983-09-30
GB2061928B (en) 1983-06-02
PL125402B1 (en) 1983-05-31
KE3461A (en) 1984-10-12
FI803239L (fi) 1981-04-16
KE3466A (en) 1984-11-09
DD154816A5 (de) 1982-04-21
PL227307A1 (ko) 1981-11-13
NL8005652A (nl) 1981-04-21
AT377513B (de) 1985-03-25
DE3038593A1 (de) 1981-04-23
YU42059B (en) 1988-04-30

Similar Documents

Publication Publication Date Title
NO154346C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO156566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner.
NO802087L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO146599C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav
SE427659B (sv) Forfarande for framstellning av terapeutiskt aktiva 1-(p-klorbensyl)-2-metyl-5-metoxi-3-indonylettiksyra-pyridylmetylestrar och derivat derav
IE44339L (en) Piperazine derivatives.
IE44030L (en) Ó-amino-ketones.
NO791237L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridinderivater
SE7613090L (sv) Pikolinsyraderivat och forfarande for framstellning derav
PT66788A (en) Process for the preparation of novel herbicidally active phenoxy-alkanecarboxylic acid derivatives and use thereof for controlling grass-like weeds
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
IE812748L (en) Pyridine derivatives as anti-inflammatory and¹immunoregulatory agents
NO171275C (no) Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika
NO149350C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopropanoylaminosyrederivater
NO147449C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt fenoksyeddiksyrederivat.
NO890056D0 (no) 2,6-diazabicyklo-heptenyl-halogenmetyl-butensyrederivat anvendbart som utgangsprodukt ved fremstilling av terapeutisk aktive cefem-4-karboksylsyrer.